Filed May 31, 2019

Serial No. 79263962

Registered Feb. 25, 2020

Registration No. 5,993,280

Class Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of leukemia; Pharmaceutical preparations for the treatment of cells; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases; Biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; Pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; Pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; Pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of central nervous system diseases; 006; 018; 044; 046; 051; 052

Case Type Trademark